|
For the Three Months
Ended June 30, |
For the Six Months
Ended June 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||
| Non-GAAP Net Loss: | ||||||||||||||||
| Net loss | $ | (16,549 | ) | $ | (12,264 | ) | $ | (36,544 | ) | $ | (22,765 | ) | ||||
| Add (deduct): | ||||||||||||||||
| Depreciation and amortization expense(1) | 2,008 | 753 | 3,807 | 1,487 | ||||||||||||
| Stock-based compensation(2) | 5,479 | 1,975 | 8,935 | 2,480 | ||||||||||||
| Amortization of lease intangible | 333 | — | 666 | — | ||||||||||||
| Amortization of deferred costs on convertible notes | 469 | — | 781 | — | ||||||||||||
| Unrealized loss on marketable securities | 332 | — | 1,190 | — | ||||||||||||
| Acquisition and other ( 3) | (1,923 | ) | — | (1,284 | ) | — | ||||||||||
| (Gain) loss on sale of property and equipment | — | (2 | ) | 71 | (2 | ) | ||||||||||
| Charitable contribution of common stock | 1,285 | — | 1,285 | — | ||||||||||||
| Impairment of long-lived assets | 119 | — | 119 | — | ||||||||||||
| Non-GAAP Net Loss | $ | (8,447 | ) | $ | (9,538 | ) | $ | (20,974 | ) | $ | (18,800 | ) | ||||
| Weighted-average number of shares outstanding used to compute Non-GAAP Net Loss per share, basic and diluted | 47,074,246 | 8,390,088 | 46,932,702 | 8,158,753 | ||||||||||||
| Non-GAAP EPS, basic and diluted | $ | (0.18 | ) | $ | (1.14 | ) | $ | (0.45 | ) | $ | (2.30 | ) | ||||
Xometry Reports Second Quarter 2022 Results
 |  | More MCAD News
|
|
RELATED NEWS
